AP Biosciences Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	1,074	1,442	278.61	1,048
Short-Term Investments	200	100	461.41	30.71
Cash & Short-Term Investments	1,274	1,542	740.02	1,079
Cash Growth	-	108.33%	-31.40%	-
Other Receivables	40.39	36.18	24.6	14.48
Receivables	40.39	36.18	24.6	14.48
Prepaid Expenses	4.24	3.63	1.03	0.85
Total Current Assets	1,319	1,581	765.64	1,094
Property, Plant & Equipment	109.88	109.33	116.41	3.02
Other Intangible Assets	3.37	3.55	4.23	5.34
Other Long-Term Assets	5.51	32.8	4.48	0.78
Total Assets	1,465	1,727	890.76	1,103
Accrued Expenses	51.94	22.64	16.72	2.48
Current Portion of Leases	11.65	11.65	11.65	-
Other Current Liabilities	7.5	5.37	2.51	2.04
Total Current Liabilities	71.09	39.67	30.88	4.52
Long-Term Leases	50.73	59.26	70.43	-
Other Long-Term Liabilities	5.54	5.46	5.35	-
Total Liabilities	127.35	104.38	106.65	4.52
Common Stock	851.13	849.87	647.48	647.48
Additional Paid-In Capital	823.59	1,197	475.92	739.72
Retained Earnings	-350.68	-422.75	-339.3	-288.54
Comprehensive Income & Other	13.59	-1.08	-	-
Shareholders' Equity	1,338	1,623	784.11	1,099
Total Liabilities & Equity	1,465	1,727	890.76	1,103
Total Debt	62.38	70.91	82.08	-
Net Cash (Debt)	1,212	1,471	657.94	1,079
Net Cash Growth	-	123.54%	-39.01%	-
Net Cash Per Share	14.25	19.53	10.16	20.49
Filing Date Shares Outstanding	85.11	84.99	64.75	56.55
Total Common Shares Outstanding	85.11	84.99	64.75	56.55
Working Capital	1,248	1,542	734.77	1,090
Book Value Per Share	15.72	19.09	12.11	19.43
Tangible Book Value	1,334	1,619	779.88	1,093
Tangible Book Value Per Share	15.68	19.05	12.04	19.33
Machinery	58.02	39.3	36.93	31.34
Construction In Progress	-	-	28.2	-
Leasehold Improvements	35.02	35.5	-	1

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.